Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Hu B, Xiong Y, Ni R, Wei L, Jiang D, Wang G, Wu D, Xu T, Zhao F, Zhu M, Wan C.

Mol Cell Biochem. 2014 Nov;396(1-2):175-85. doi: 10.1007/s11010-014-2153-9. Epub 2014 Aug 1.

PMID:
25081333
2.

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.

J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5.

PMID:
26438629
3.

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.

World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

4.

Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.

Sun J, Luo Y, Tian Z, Gu L, Xia SC, Yu Y.

BMC Cancer. 2012 Oct 30;12:499. doi: 10.1186/1471-2407-12-499.

5.

Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.

He HC, Ling XH, Zhu JG, Fu X, Han ZD, Liang YX, Deng YH, Lin ZY, Chen G, Chen YF, Mo RJ, Zhong WD.

Mol Biol Rep. 2013 May;40(5):3799-805. doi: 10.1007/s11033-012-2458-2. Epub 2013 Jan 3.

PMID:
23283744
6.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567
7.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
8.

Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.

Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.

Dig Dis Sci. 2017 Jan;62(1):133-142. doi: 10.1007/s10620-016-4365-1. Epub 2016 Dec 5.

PMID:
27921263
9.

Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.

Qiu H, Zhang X, Ni W, Shi W, Fan H, Xu J, Chen Y, Ni R, Tao T.

Dig Dis Sci. 2016 Mar;61(3):795-805. doi: 10.1007/s10620-015-3937-9. Epub 2015 Nov 9.

PMID:
26553251
10.

Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.

Shi W, Huang W, Chen Y, Zhang S, Xu P, Gu X, Fan H, Xu J, Chen Y, Ni R, Lu C, Zhang X.

Tumour Biol. 2016 Aug;37(8):10447-57. doi: 10.1007/s13277-015-4556-y. Epub 2016 Feb 5.

PMID:
26846109
11.

High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.

Huang W, Cui X, Chen Y, Shao M, Shao X, Shen Y, Liu Q, Wu M, Liu J, Ni W, Lu C, Wan C.

Pathol Res Pract. 2016 Mar;212(3):171-8. doi: 10.1016/j.prp.2015.11.015. Epub 2015 Nov 28.

PMID:
26706601
12.

High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Liu G, Huang X, Cui X, Zhang J, Wei L, Ni R, Lu C.

Med Oncol. 2013;30(3):537. doi: 10.1007/s12032-013-0537-4. Epub 2013 May 22.

PMID:
23696020
13.

Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.

Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.

Dig Dis Sci. 2015 Nov;60(11):3351-63. doi: 10.1007/s10620-015-3774-x. Epub 2015 Jun 30.

PMID:
26123838
14.

Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.

Yang L, Hu B, Zhang Y, Qiang S, Cai J, Huang W, Gong C, Zhang T, Zhang S, Xu P, Wu X, Liu J.

Med Oncol. 2015 Apr;32(4):128. doi: 10.1007/s12032-015-0559-1. Epub 2015 Mar 21.

PMID:
25794490
15.

A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.

Liu F, Zhu C, Huang X, Cai J, Wang H, Wang X, He S, Liu C, Yang X, Zhang Y, Zhang T.

Pathol Res Pract. 2014 Dec;210(12):885-92. doi: 10.1016/j.prp.2014.07.011. Epub 2014 Aug 9.

PMID:
25169131
16.

High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).

Gong C, Zhang Y, Chen Y, Zhang H, Liu X, Xue H, Ji L, Wang L, Yang L, Zhou G, Wan C.

Tumour Biol. 2015 Dec;36(12):9189-99. doi: 10.1007/s13277-015-3625-6. Epub 2015 Jun 19.

PMID:
26088450
17.

Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.

Zhang X, Xu P, Ni W, Fan H, Xu J, Chen Y, Huang W, Lu S, Liang L, Liu J, Chen B, Shi W.

Pathol Res Pract. 2016 Mar;212(3):162-70. doi: 10.1016/j.prp.2016.01.002. Epub 2016 Jan 7.

PMID:
26804244
18.

Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.

Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H, Zhang Z.

Int J Cancer. 2007 May 1;120(9):1909-13.

19.

Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.

Huang X, Cong X, Yang D, Ji L, Liu Y, Cui X, Cai J, He S, Zhu C, Ni R, Zhang Y.

Pathol Res Pract. 2014 Nov;210(11):719-25. doi: 10.1016/j.prp.2014.07.001. Epub 2014 Jul 17.

PMID:
25155751
20.

Potential therapeutic strategy for oral squamous cell carcinoma by ErbB3-binding protein 1 gene transfer.

Zhou X, Chen W, Zhang Y, Sun J, Wang Q, Yu Y.

J Cancer Res Clin Oncol. 2010 Jun;136(6):891-6. doi: 10.1007/s00432-009-0730-1. Epub 2009 Nov 24.

PMID:
19937055

Supplemental Content

Support Center